Ftse Mib
33.986,90
0,00%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.580,73
0,66%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Immunovia Ab (publ) (0G8X) Immunovia Ab (publ) (0G8X) Notizie

0G8X

Immunovia Ab (publ) (0G8X)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0G8X
DataOraFonteTitoloSimboloCompagnia
04/01/202416:59PR Newswire (US)Immunovia announces financial calendar for financial year 2024LSE:0G8XImmunovia Ab (publ)
21/11/202311:40PR Newswire (US)Bulletin from the extraordinary general meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
09/11/202309:03PR Newswire (US)Immunovia Publishes Interim Report for January-September 2023LSE:0G8XImmunovia Ab (publ)
07/11/202316:14PR Newswire (US)Immunovia successfully completes discovery phase of next-generation test developmentLSE:0G8XImmunovia Ab (publ)
02/11/202311:02PR Newswire (US)Invitation to Immunovia's Q3 presentationLSE:0G8XImmunovia Ab (publ)
27/10/202309:06PR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)LSE:0G8XImmunovia Ab (publ)
03/10/202311:01PR Newswire (US)Nomination Committee appointed for Immunovia AB (Publ)LSE:0G8XImmunovia Ab (publ)
30/08/202312:30PR Newswire (US)Immunovia Publishes Interim Report for January-June 2023LSE:0G8XImmunovia Ab (publ)
23/08/202320:08PR Newswire (US)Invitation to Immunovia's Q2 presentationLSE:0G8XImmunovia Ab (publ)
19/07/202318:47PR Newswire (US)Immunovia announces updated financial calendarLSE:0G8XImmunovia Ab (publ)
12/07/202309:15PR Newswire (US)Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer DetectionLSE:0G8XImmunovia Ab (publ)
09/06/202310:19PR Newswire (US)Chief Executive Officer, Jeff Borcherding, buys Immunovia sharesLSE:0G8XImmunovia Ab (publ)
31/05/202312:16PR Newswire (US)Change in number of shares and votes in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
26/05/202313:43PR Newswire (US)Bulletin from the Annual General Meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
23/05/202309:03PR Newswire (US)Immunovia Publishes Interim Report for January-March 2023LSE:0G8XImmunovia Ab (publ)
22/05/202318:55PR Newswire (US)Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
17/05/202310:43PR Newswire (US)Invitation to Immunovia's Q1 presentationLSE:0G8XImmunovia Ab (publ)
06/05/202313:40PR Newswire (US)The board member Philipp von Hugo resigns from Immunovia's board at his own requestLSE:0G8XImmunovia Ab (publ)
30/04/202312:17PR Newswire (US)Immunovia AB appoints new CEOLSE:0G8XImmunovia Ab (publ)
26/04/202314:44PR Newswire (US)Immunovia to discuss adoption of IMMray™ PanCan-d with key opinion leaders on May 3, 2023LSE:0G8XImmunovia Ab (publ)
25/04/202309:02PR Newswire (US)CONVENING NOTICE - ANNUAL GENERAL MEETING IN IMMUNOVIA AB (publ)LSE:0G8XImmunovia Ab (publ)
21/04/202317:25PR Newswire (US)Immunovia publishes the annual report for 2022LSE:0G8XImmunovia Ab (publ)
20/04/202308:54PR Newswire (US)Immunovia to participate in National Pancreas Foundation Webinar on Biomarkers and Liquid Biopsy for Early Detection of Pancreatic CancerLSE:0G8XImmunovia Ab (publ)
12/04/202319:06PR Newswire (US)Immunovia announces outcome of the rights issueLSE:0G8XImmunovia Ab (publ)
17/03/202313:34PR Newswire (US)Immunovia publishes prospectus relating to the rights issueLSE:0G8XImmunovia Ab (publ)
01/03/202308:41PR Newswire (US)Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operationsLSE:0G8XImmunovia Ab (publ)
23/02/202308:54PR Newswire (US)Immunovia Publishes Full Year Report for 2022LSE:0G8XImmunovia Ab (publ)
20/02/202315:37PR Newswire (US)Invitation to Immunovia's Q4 presentationLSE:0G8XImmunovia Ab (publ)
20/02/202308:44PR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (publ)LSE:0G8XImmunovia Ab (publ)
20/02/202308:13PR Newswire (US)Immunovia resolves on a rights issue of approximately SEK 202.2 million and postpones the publication of the quarterly report for the first quarter and the annual general meetingLSE:0G8XImmunovia Ab (publ)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0G8X

La tua Cronologia

BIT
11COV
Covestro
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network